Kevin Thomas Ferro
Chief Executive Officer chez Ferro Holdings LLC (New York)
Profil
Mr. Kevin T.
Ferro is a Chief Executive Officer at Ferro Holdings LLC (New York), a Founder, Chief Executive Officer at Vatera Healthcare Partners, a Chairman at Arisaph Pharmaceuticals, Inc. and a Chairman at ImmusanT, Inc. He is on the Board of Directors at Ekteino Laboratories, Inc.
Mr. Ferro was previously employed as an Independent Director by Greenhill & Co., Inc., a Chairman by Melinta Therapeutics, Inc., a Chairman by Pearl Therapeutics, Inc., a Chief Executive & Investment Officer by Oikos Holdings LLC, a Chief Executive Officer & Investment Officer by Ferro Capital LLC, a Global Head-Alternative Investment Strategies by Commerzbank AG, and a Vice President by D.
E.
Shaw & Co. LP.
He also served on the board at KOS Pharmaceuticals, Inc., Eltrak SA and Melinta Subsidiary Corp.
He received his undergraduate degree from Harvard University.
Postes actifs de Kevin Thomas Ferro
| Sociétés | Poste | Début |
|---|---|---|
Arisaph Pharmaceuticals, Inc.
 Arisaph Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arisaph Pharmaceuticals, Inc. provides drug discovery services. It has various drug discovery programs to develop therapies for diabetes, cancer, and cardiovascular disease. The company was founded by Michael Jaharis, Christopher P. Kiritsy, and William Bachovchin in 1999 and is headquartered in Boston, MA | Chairman | 01/01/2005 |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Chairman | - |
Ekteino Laboratories, Inc.
 Ekteino Laboratories, Inc. BiotechnologyHealth Technology Ekteino Laboratories, Inc. develops sustained-release drug delivery systems for chronic use medications. The private company is based in New York, NY. | Director/Board Member | - |
Ferro Holdings LLC (New York)
 Ferro Holdings LLC (New York) Financial ConglomeratesFinance Ferro Holdings LLC was founded by Kevin Thomas Ferro and he has been the CEO since incorporation. The American company functions as an investment holding company. | Chief Executive Officer | 01/08/2019 |
Anciens postes connus de Kevin Thomas Ferro
| Sociétés | Poste | Fin |
|---|---|---|
| GREENHILL & CO., INC. | Director/Board Member | 30/11/2023 |
| MELINTA THERAPEUTICS, INC. | Chairman | 05/08/2019 |
Oikos Holdings LLC
 Oikos Holdings LLC Investment ManagersFinance Oikos Holdings LLC is a financial advisory services holding private company. The company is based in New York, NY and has subsidiaries in the United States. The company was founded by Kevin Thomas Ferro. | Chief Executive Officer | 31/12/2018 |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Chairman | 01/06/2013 |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Director/Board Member | - |
Formation de Kevin Thomas Ferro
| Harvard University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| COMMERZBANK AG | Finance |
| GREENHILL & CO., INC. | Finance |
| Entreprise privées | 12 |
|---|---|
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Health Technology |
D. E. Shaw & Co. LP
 D. E. Shaw & Co. LP Investment ManagersFinance D. E. Shaw & Co. LP (DESCO) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 1992 by David Elliot Shaw. DESCO serves as the managing member, manager and/or investment advisor of certain entities in the D. E. Shaw Group and provides investment advice to a number of affiliated hedge funds and other entities. The investor base of the funds includes institutional investors and other highly sophisticated, high-net worth participants. | Finance |
Arisaph Pharmaceuticals, Inc.
Arisaph Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arisaph Pharmaceuticals, Inc. provides drug discovery services. It has various drug discovery programs to develop therapies for diabetes, cancer, and cardiovascular disease. The company was founded by Michael Jaharis, Christopher P. Kiritsy, and William Bachovchin in 1999 and is headquartered in Boston, MA | Health Technology |
Eltrak SA
 Eltrak SA Wholesale DistributorsDistribution Services Eltrak SA engages in the development and distribution of vehicle equipment, tires, and automobile parts. It operates trough the Machinery and Tire segments. The firm offers rental solutions for construction companies, contractors, plumbers, electricians, and municipalities such as earthmoving machines, skid steer loaders, mini excavators, backhoe loaders, and sound attenuated electric power generators. The company was founded on June 15, 1982 and is headquartered in Athens, Greece. | Distribution Services |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
Oikos Holdings LLC
Oikos Holdings LLC Investment ManagersFinance Oikos Holdings LLC is a financial advisory services holding private company. The company is based in New York, NY and has subsidiaries in the United States. The company was founded by Kevin Thomas Ferro. | Finance |
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Health Technology |
Ferro Capital LLC
 Ferro Capital LLC Investment ManagersFinance Ferro Capital LLC provides investment advice. The private company is based in New York, NY and has subsidiaries in Cayman Islands and United States. The company was founded by Kevin Thomas Ferro. | Finance |
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Health Technology |
Ekteino Laboratories, Inc.
Ekteino Laboratories, Inc. BiotechnologyHealth Technology Ekteino Laboratories, Inc. develops sustained-release drug delivery systems for chronic use medications. The private company is based in New York, NY. | Health Technology |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
Ferro Holdings LLC (New York)
Ferro Holdings LLC (New York) Financial ConglomeratesFinance Ferro Holdings LLC was founded by Kevin Thomas Ferro and he has been the CEO since incorporation. The American company functions as an investment holding company. | Finance |
